Researchers from the University of British Columbia and Vancouver Coastal Health Research Institute have found that a widely prescribed drug for multiple sclerosis (MS) is associated with longer survival for patients. The study, published today in the journal Brain, found that people with MS who took a beta interferon drug had a 32 per cent

What to know about itching and MS Multiple sclerosis is a condition that affects the central nervous system. Its symptoms affect the nerves and can cause dysesthesia, or abnormal sensations such as burning, numbness, or itching. https://www.medicalnewstoday.com/articles/323838.php

What do brain lesions mean in multiple sclerosis? Magnetic resonance imaging is an important diagnostic tool for multiple sclerosis because it produces images of lesions in the brain and spinal cord. These lesions can appear as the condition progresses, and they may have a bearing on the symptoms that occur. https://www.medicalnewstoday.com/articles/323976.php

Intermittent fasting may benefit people with MS In multiple sclerosis, the immune system mistakenly attacks and harms myelin, which is the “sheath” that protects axons (or the projection that links nerve cells to one another and lets them communicate). This can result in muscle weakness, fatigue, coordination problems, and chronic pain.

Advanced MRI technique predicts risk of disease progression in MS A study led by researchers at the University of Buffalo has shown that an advanced MRI technique can help to identify patients with multiple sclerosis (MS) who are at an increased risk of developing a physical disability.

MS: Iron levels in brain ‘predict disability’ Mapping iron levels in the brain with a noninvasive scan could help identify multiple sclerosis patients at higher risk of future physical disability.

Where a protein is expressed can influence its action. University of Pennsylvania researchers and colleagues have identified one that plays a key role in getting the body back to normal after inflammation. https://www.news-medical.net/news/20181120/Location-matters-for-inflammation-clearance.aspx

Mapping of a certain group of cells, known as oligodendrocytes, in the central nervous system of a mouse model of multiple sclerosis (MS), shows that they might have a significant role in the development of the disease. The discovery can lead to new therapies targeted at other areas than just the immune system. The results

New research, published in the journal Nature Immunology, now shows how a high intake of salt may cause inflammation in multiple sclerosis. https://www.medicalnewstoday.com/articles/323558.php